US Stock MarketDetailed Quotes

NBIX Neurocrine Biosciences

Watchlist

125.650
+0.650+0.52%

Close Nov 22 16:00 ET

125.650
0.0000.00%

Post 20:01 ET

12.72BMarket Cap33.51P/E (TTM)

Neurocrine Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-25.47%158M

-64.03%64.6M

204.07%130.3M

14.88%389.9M

-13.64%123.5M

114.57%212M

30.05%179.6M

-209.14%-125.2M

32.32%339.4M

3,304.76%143M

Net income from continuing operations

56.20%129.8M

-31.94%65M

156.66%43.4M

61.62%249.7M

65.96%147.7M

21.31%83.1M

665.09%95.5M

-651.08%-76.6M

72.43%154.5M

1,319.18%89M

Operating gains losses

----

--70M

--0

Depreciation and amortization

18.18%6.5M

43.14%7.3M

24.00%6.2M

36.54%21.3M

29.55%5.7M

37.50%5.5M

30.77%5.1M

51.52%5M

43.12%15.6M

46.67%4.4M

Deferred tax

-730.95%-34.9M

0.48%-41.3M

50.63%-15.6M

-396.86%-56.7M

52.59%20.6M

-146.67%-4.2M

-1,238.71%-41.5M

-10,433.33%-31.6M

344.19%19.1M

387.23%13.5M

Other non cash items

-65.04%-20.3M

25,050.00%49.9M

92,200.00%92.1M

-112.50%-200K

616.67%12.4M

-1,466.67%-12.3M

-110.53%-200K

-108.33%-100K

-88.81%1.6M

61.90%-2.4M

Change In working capital

-90.43%4.4M

-192.40%-86.3M

45.04%-31.6M

141.84%28.2M

-3,480.00%-53.7M

394.87%46M

267.72%93.4M

24.04%-57.5M

-503.59%-67.4M

-130.61%-1.5M

-Change in receivables

57.57%-12.9M

-519.05%-17.6M

72.90%-11.3M

44.94%-89.3M

53.98%-21.4M

-36.94%-30.4M

127.10%4.2M

46.54%-41.7M

-471.13%-162.2M

-114.29%-46.5M

-Change in inventory

-213.79%-3.3M

-431.25%-5.3M

-38.89%1.1M

307.69%5.4M

-123.08%-900K

137.66%2.9M

633.33%1.6M

20.00%1.8M

-4.00%-2.6M

178.00%3.9M

-Change in payables and accrued expense

-68.33%39.4M

-467.28%-59.5M

-377.61%-18.6M

-43.89%64.3M

-320.74%-83M

279.27%124.4M

-50.46%16.2M

-41.74%6.7M

101.76%114.6M

96.86%37.6M

-Change in other working capital

63.06%-18.8M

-105.46%-3.9M

88.48%-2.8M

377.91%47.8M

1,374.29%51.6M

-175.14%-50.9M

740.00%71.4M

-127.10%-24.3M

-86.96%-17.2M

-72.00%3.5M

Cash from discontinued investing activities

Operating cash flow

-25.47%158M

-64.03%64.6M

204.07%130.3M

14.88%389.9M

-13.64%123.5M

114.57%212M

30.05%179.6M

-209.14%-125.2M

32.32%339.4M

3,304.76%143M

Investing cash flow

Cash flow from continuing investing activities

125.39%24.7M

77.60%-28.2M

-30.64%-55M

-163.75%-467.1M

-74.57%-201.8M

-58.73%-97.3M

-500.96%-125.9M

-33.23%-42.1M

-36.02%-177.1M

-587.76%-115.6M

Capital expenditure reported

-6.58%-8.1M

-70.59%-11.6M

-31.76%-11.2M

-71.52%-28.3M

-200.00%-5.4M

-547.06%-7.6M

22.73%-6.8M

-11.84%-8.5M

29.49%-16.5M

79.78%-1.8M

Net business purchase and sale

----

--0

----

---42.7M

----

Net investment purchase and sale

136.57%32.8M

86.06%-16.6M

-30.36%-43.8M

-272.18%-438.8M

-176.23%-196.4M

-42.38%-89.7M

-396.27%-119.1M

-40.00%-33.6M

-10.39%-117.9M

-318.10%-71.1M

Cash from discontinued investing activities

Investing cash flow

125.39%24.7M

77.60%-28.2M

-30.64%-55M

-163.75%-467.1M

-74.57%-201.8M

-58.73%-97.3M

-500.96%-125.9M

-33.23%-42.1M

-36.02%-177.1M

-587.76%-115.6M

Financing cash flow

Cash flow from continuing financing activities

40.43%26.4M

-10,203.45%-293M

752.44%69.9M

127.87%65.3M

43.90%35.4M

64.91%18.8M

101.05%2.9M

34.43%8.2M

-955.11%-234.3M

1,266.67%24.6M

Net issuance payments of debt

--0

----

--0

----

-278,900.00%-279M

--0

Proceeds from stock option exercised by employees

40.43%26.4M

444.83%15.8M

752.44%69.9M

46.09%65.3M

43.90%35.4M

64.91%18.8M

11.54%2.9M

34.43%8.2M

62.55%44.7M

1,266.67%24.6M

Cash from discontinued financing activities

Financing cash flow

40.43%26.4M

-10,203.45%-293M

752.44%69.9M

127.87%65.3M

43.90%35.4M

64.91%18.8M

101.05%2.9M

34.43%8.2M

-955.11%-234.3M

1,266.67%24.6M

Net cash flow

Beginning cash position

-12.19%147.7M

262.28%404.3M

-4.29%259.1M

-21.31%270.7M

37.14%301.7M

-1.69%168.2M

-59.86%111.6M

-21.31%270.7M

80.77%344M

-30.00%220M

Current changes in cash

56.63%209.1M

-553.36%-256.6M

191.26%145.2M

83.47%-11.9M

-182.50%-42.9M

173.01%133.5M

152.95%56.6M

-141.06%-159.1M

-146.84%-72M

75.08%52M

Effect of exchange rate changes

----

123.08%300K

--300K

----

---1.3M

----

End cash Position

18.36%357.1M

-12.19%147.7M

262.28%404.3M

-4.29%259.1M

37.14%301.7M

-1.69%168.2M

-59.86%111.6M

-21.31%270.7M

Free cash flow

-26.66%149.9M

-69.33%53M

189.08%119.1M

11.99%361.6M

-16.36%118.1M

103.38%204.4M

33.64%172.8M

-177.96%-133.7M

38.52%322.9M

3,104.26%141.2M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-25.47%158M	-64.03%64.6M	204.07%130.3M	14.88%389.9M	-13.64%123.5M	114.57%212M	30.05%179.6M	-209.14%-125.2M	32.32%339.4M	3,304.76%143M
Net income from continuing operations	56.20%129.8M	-31.94%65M	156.66%43.4M	61.62%249.7M	65.96%147.7M	21.31%83.1M	665.09%95.5M	-651.08%-76.6M	72.43%154.5M	1,319.18%89M
Operating gains losses	----	----	----	----	----	----	----	----	--70M	--0
Depreciation and amortization	18.18%6.5M	43.14%7.3M	24.00%6.2M	36.54%21.3M	29.55%5.7M	37.50%5.5M	30.77%5.1M	51.52%5M	43.12%15.6M	46.67%4.4M
Deferred tax	-730.95%-34.9M	0.48%-41.3M	50.63%-15.6M	-396.86%-56.7M	52.59%20.6M	-146.67%-4.2M	-1,238.71%-41.5M	-10,433.33%-31.6M	344.19%19.1M	387.23%13.5M
Other non cash items	-65.04%-20.3M	25,050.00%49.9M	92,200.00%92.1M	-112.50%-200K	616.67%12.4M	-1,466.67%-12.3M	-110.53%-200K	-108.33%-100K	-88.81%1.6M	61.90%-2.4M
Change In working capital	-90.43%4.4M	-192.40%-86.3M	45.04%-31.6M	141.84%28.2M	-3,480.00%-53.7M	394.87%46M	267.72%93.4M	24.04%-57.5M	-503.59%-67.4M	-130.61%-1.5M
-Change in receivables	57.57%-12.9M	-519.05%-17.6M	72.90%-11.3M	44.94%-89.3M	53.98%-21.4M	-36.94%-30.4M	127.10%4.2M	46.54%-41.7M	-471.13%-162.2M	-114.29%-46.5M
-Change in inventory	-213.79%-3.3M	-431.25%-5.3M	-38.89%1.1M	307.69%5.4M	-123.08%-900K	137.66%2.9M	633.33%1.6M	20.00%1.8M	-4.00%-2.6M	178.00%3.9M
-Change in payables and accrued expense	-68.33%39.4M	-467.28%-59.5M	-377.61%-18.6M	-43.89%64.3M	-320.74%-83M	279.27%124.4M	-50.46%16.2M	-41.74%6.7M	101.76%114.6M	96.86%37.6M
-Change in other working capital	63.06%-18.8M	-105.46%-3.9M	88.48%-2.8M	377.91%47.8M	1,374.29%51.6M	-175.14%-50.9M	740.00%71.4M	-127.10%-24.3M	-86.96%-17.2M	-72.00%3.5M
Cash from discontinued investing activities
Operating cash flow	-25.47%158M	-64.03%64.6M	204.07%130.3M	14.88%389.9M	-13.64%123.5M	114.57%212M	30.05%179.6M	-209.14%-125.2M	32.32%339.4M	3,304.76%143M
Investing cash flow
Cash flow from continuing investing activities	125.39%24.7M	77.60%-28.2M	-30.64%-55M	-163.75%-467.1M	-74.57%-201.8M	-58.73%-97.3M	-500.96%-125.9M	-33.23%-42.1M	-36.02%-177.1M	-587.76%-115.6M
Capital expenditure reported	-6.58%-8.1M	-70.59%-11.6M	-31.76%-11.2M	-71.52%-28.3M	-200.00%-5.4M	-547.06%-7.6M	22.73%-6.8M	-11.84%-8.5M	29.49%-16.5M	79.78%-1.8M
Net business purchase and sale	----	----	----	--0	----	----	----	----	---42.7M	----
Net investment purchase and sale	136.57%32.8M	86.06%-16.6M	-30.36%-43.8M	-272.18%-438.8M	-176.23%-196.4M	-42.38%-89.7M	-396.27%-119.1M	-40.00%-33.6M	-10.39%-117.9M	-318.10%-71.1M
Cash from discontinued investing activities
Investing cash flow	125.39%24.7M	77.60%-28.2M	-30.64%-55M	-163.75%-467.1M	-74.57%-201.8M	-58.73%-97.3M	-500.96%-125.9M	-33.23%-42.1M	-36.02%-177.1M	-587.76%-115.6M
Financing cash flow
Cash flow from continuing financing activities	40.43%26.4M	-10,203.45%-293M	752.44%69.9M	127.87%65.3M	43.90%35.4M	64.91%18.8M	101.05%2.9M	34.43%8.2M	-955.11%-234.3M	1,266.67%24.6M
Net issuance payments of debt	--0	----	----	--0	--0	--0	----	----	-278,900.00%-279M	--0
Proceeds from stock option exercised by employees	40.43%26.4M	444.83%15.8M	752.44%69.9M	46.09%65.3M	43.90%35.4M	64.91%18.8M	11.54%2.9M	34.43%8.2M	62.55%44.7M	1,266.67%24.6M
Cash from discontinued financing activities
Financing cash flow	40.43%26.4M	-10,203.45%-293M	752.44%69.9M	127.87%65.3M	43.90%35.4M	64.91%18.8M	101.05%2.9M	34.43%8.2M	-955.11%-234.3M	1,266.67%24.6M
Net cash flow
Beginning cash position	-12.19%147.7M	262.28%404.3M	-4.29%259.1M	-21.31%270.7M	37.14%301.7M	-1.69%168.2M	-59.86%111.6M	-21.31%270.7M	80.77%344M	-30.00%220M
Current changes in cash	56.63%209.1M	-553.36%-256.6M	191.26%145.2M	83.47%-11.9M	-182.50%-42.9M	173.01%133.5M	152.95%56.6M	-141.06%-159.1M	-146.84%-72M	75.08%52M
Effect of exchange rate changes	----	----	----	123.08%300K	--300K	----	----	----	---1.3M	----
End cash Position	18.36%357.1M	-12.19%147.7M	262.28%404.3M	-4.29%259.1M	-4.29%259.1M	37.14%301.7M	-1.69%168.2M	-59.86%111.6M	-21.31%270.7M	-21.31%270.7M
Free cash flow	-26.66%149.9M	-69.33%53M	189.08%119.1M	11.99%361.6M	-16.36%118.1M	103.38%204.4M	33.64%172.8M	-177.96%-133.7M	38.52%322.9M	3,104.26%141.2M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data